Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Eisenhower Medical Center
1075
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Annie Penn Memorial Hospital
1004
mi
from
Reidsville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente-Richmond
1334
mi
from
Richmond, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
The Valley Hospital
1281
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Cancer Therapy and Integrative Medicine
958
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
21st Century Oncology - Vegas Tenaya
960
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada
970
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Geisinger Medical Oncology-Lewisburg
1137
mi
from
Lewisburg, PA
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Kaiser Permanente-Cadillac
1177
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Jewish Hospital Medical Center Northeast
674
mi
from
Louisville, KY
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Saint John's Hospital - Healtheast
559
mi
from
Maplewood, MN
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Riddle Memorial Hospital
1212
mi
from
Media, PA
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Luke's Mountain States Tumor Institute - Meridian
1050
mi
from
Meridian, ID
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Alegent Health Immanuel Medical Center
267
mi
from
Omaha, NE
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Hematology and Oncology Consultants PC
267
mi
from
Omaha, NE
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Alegent Health Bergan Mercy Medical Center
258
mi
from
Omaha, NE
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Creighton University Medical Center
262
mi
from
Omaha, NE
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Kaiser Permanente - Panorama City
1176
mi
from
Panorama City, CA
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Paoli Memorial Hospital
1208
mi
from
Paoli, PA
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Rocky Mountain Cancer Centers-Parker
393
mi
from
Parker, CO
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Illinois CancerCare - Pekin
486
mi
from
Pekin, IL
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Valley Radiation Oncology
524
mi
from
Peru, IL
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Joseph Mercy Oakland
835
mi
from
Pontiac, MI
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Mary's Regional Medical Center
1191
mi
from
Reno, NV
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Park Nicollet Clinic - Saint Louis Park
548
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Regions Hospital
554
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
United Hospital
552
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Kaiser Permanente-Santa Teresa-San Jose
1314
mi
from
San Jose, CA
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Swedish Medical Center - Cherry Hill
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Francis Regional Medical Center
535
mi
from
Shakopee, MN
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Southern Illinois University School of Medicine
462
mi
from
Springfield, IL
Click here to add this to my saved trials
Dental / Maxillofacial Surgery Clinical Trial
DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Lakes Research
1309
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Dental / Maxillofacial Surgery Clinical Trial
DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Tulane University
697
mi
from
New Orleans, LA
Click here to add this to my saved trials
Dental / Maxillofacial Surgery Clinical Trial
DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Carle Cancer Center
541
mi
from
Urbana, IL
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1149
mi
from
Baltimore, MD
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer and Metastatic Melanoma Receiving Post-progression Immune Checkpoint Inhibitor Therapy
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Safety and Dose Escalation Study of an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia A Subjects
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Medical University of South Carolina
1063
mi
from
Charleston, SC
Click here to add this to my saved trials
Pancreatic Adenocarcinoma Clinical Trial
Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Pennsylvania:Abramson Cancer Center
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Friedreich Ataxia Clinical Trial
Neurology Measures in FA Children
Status: Enrolling, Phase
Updated: 12/31/1969
University of California at Los Angeles
1177
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Premature Birth of Newborn Clinical Trial
Improving Preterm Infant Outcomes With Family Integrated Care and Mobile Technology
Status: Enrolling
Updated: 12/31/1969
Community Regional Medical Center
1207
mi
from
Fresno, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
West Michigan Cancer Center
718
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Lehigh Valley Hospital-Cedar Crest
1207
mi
from
Allentown, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Alaska Medical Center
2732
mi
from
Anchorage, AK
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Emory Saint Joseph's Hospital
798
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Emory University Hospital Midtown
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Rush - Copley Medical Center
575
mi
from
Aurora, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Flaget Memorial Hospital
670
mi
from
Bardstown, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Ochsner Health Center-Summa
638
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois CancerCare-Bloomington
511
mi
from
Bloomington, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Luke's Mountain States Tumor Institute
1039
mi
from
Boise, ID
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Bozeman Deaconess Hospital
871
mi
from
Bozeman, MT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Harrison HealthPartners Hematology and Oncology-Bremerton
1422
mi
from
Bremerton, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Francis Medical Center
454
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Dayton Physicians LLC-Miami Valley South
746
mi
from
Centerville, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Geauga Hospital
920
mi
from
Chardon, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Hospital
722
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Hematology Care Inc - Kenwood
732
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
TriHealth Cancer Institute-Westside
718
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clackamas Radiation Oncology Center
1375
mi
from
Clackamas, OR
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Oncology and Hematology Care Southeast
1377
mi
from
Clackamas, OR
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Samaritan North Health Center
746
mi
from
Dayton, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Medical Center- Fairlane
835
mi
from
Dearborn, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical Oncology and Hematology Associates-Laurel
347
mi
from
Des Moines, IA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Hospital
841
mi
from
Detroit, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint John Hospital and Medical Center
841
mi
from
Detroit, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Pocono Medical Center
1226
mi
from
East Stroudsburg, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Carle Physician Group-Effingham
510
mi
from
Effingham, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Epic Care Partners in Cancer Care
1331
mi
from
Emeryville, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Broward Health Medical Center
1308
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Fresno Cancer Center
1205
mi
from
Fresno, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-Fresno
1206
mi
from
Fresno, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Unity Hospital
559
mi
from
Fridley, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois CancerCare - Galesburg
455
mi
from
Galesburg, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Tacoma/Valley Radiation Oncology Centers-Gig Harbor
1416
mi
from
Gig Harbor, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Falls Clinic
958
mi
from
Great Falls, MT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Dayton Physicians LLC-Wayne
726
mi
from
Greenville, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System Cancer Institute-Butternut
883
mi
from
Greenville, SC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Queen's Medical Center
3717
mi
from
Honolulu, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Hawaii Cancer Center
3717
mi
from
Honolulu, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Straub Clinic And Hospital
3717
mi
from
Honolulu, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kuakini Medical Center
3718
mi
from
Honolulu, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kadlec Clinic Hematology and Oncology
1236
mi
from
Kennewick, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Minimally Invasive Surgery Hospital
184
mi
from
Lenexa, KS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Hospital East
729
mi
from
Lexington, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Mary Mercy Hospital
827
mi
from
Livonia, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-Lone Tree
401
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Minnesota Oncology Hematology PA-Maplewood
559
mi
from
Maplewood, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint John's Hospital - Healtheast
559
mi
from
Maplewood, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Contra Costa Regional Medical Center
1321
mi
from
Martinez, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Riddle Memorial Hospital
1212
mi
from
Media, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist Memorial Hospital for Women
467
mi
from
Memphis, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Luke's Mountain States Tumor Institute - Meridian
1050
mi
from
Meridian, ID
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Health Mercy Campus
715
mi
from
Muskegon, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Newton Memorial Hospital
1248
mi
from
Newton, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Medical Center-Columbus
824
mi
from
Novi, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Oklahoma Health Sciences Center
153
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Creighton University Medical Center
262
mi
from
Omaha, NE
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Kansas Cancer Center - Overland Park
187
mi
from
Overland Park, KS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Luke's South Hospital
190
mi
from
Overland Park, KS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Paoli Memorial Hospital
1208
mi
from
Paoli, PA
Click here to add this to my saved trials